Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Fresenius Medical Care Nephrologica Deutschland GmbH, Else-Kröner-Straße 1, 61352 Bad Homburg v.d.H., Germany
Osvaren 435 mg/235 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. White to yellowish, oblong film-coated tablet with a single score line. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. |
Each film-coated tablet contains: Calcium acetate, 435 mg equivalent to 110 mg calcium and Magnesium carbonate, heavy 235 mg equivalent to 60 mg magnesium.
Excipients with known effect: Each film-coated tablet contains 5.6 mg sodium and 50 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Calcium acetate |
Calcium is an endogenous ion of the body essential for the maintenance of a number of physiologic processes. It participates as an integral factor in the maintenance of the functional integrity of the nervous system, in the contractile mechanisms of muscle tissue, in the clotting of blood, and in the formation of the major structural material of the skeleton. Soluble calcium salts are commonly used in the treatment of calcium deficiency. |
|
| Magnesium carbonate |
Magnesium carbonate, MgCO3 (archaic name magnesia alba), is an inorganic salt. The most common magnesium carbonate forms are the anhydrous salt called magnesite (MgCO3) and the di, tri, and pentahydrates known as barringtonite (MgCO3·2 H2O), nesquehonite (MgCO3·3 H2O), and lansfordite (MgCO3·5 H2O), respectively. The primary use of magnesium carbonate is the production of magnesium oxide by calcining. |
| List of Excipients |
|---|
|
Tablet core: Starch, pregelatinised, from maize Film coating: Castor oil, refined |
HDPE container with LDPE cap: Pack size of 180 film-coated tablets.
Fresenius Medical Care Nephrologica Deutschland GmbH, Else-Kröner-Straße 1, 61352 Bad Homburg v.d.H., Germany
PL 29386/0005
Date of first authorisation: 11.03.2008
Date of latest renewal: 03.01.2011
| Drug | Countries | |
|---|---|---|
| OSVAREN | Austria, Estonia, Spain, France, Croatia, Lithuania, Netherlands, Romania, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
